Skip to main content
新芝生物 logo

新芝生物 — Investor Relations & Filings

Ticker · 920685 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 390 across all filing types
Latest filing 2023-10-24 Capital/Financing Update
Country CN China
Listing Beijing Stock Exchange 920685

About 新芝生物

https://www.scientz.com/

Scientz Biotechnology specializes in the design and manufacture of high-performance life science instruments and laboratory equipment. The product range features ultrasonic cell disruptors, freeze dryers, gene guns, and high-pressure homogenizers, which are essential for sample preparation, cell lysis, and genetic engineering. The company also provides specialized solutions for tissue grinding, ultrasonic cleaning, and precise temperature control. These instruments serve a broad spectrum of applications in molecular biology, pharmaceutical research, environmental science, and agricultural technology. By integrating advanced ultrasonic and cryogenic technologies, Scientz supports research institutions and industrial laboratories in achieving accurate and reproducible results across various scientific disciplines.

Recent filings

Filing Released Lang Actions
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo Xinzhi Biotechnology Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It details the authorization, types of financial products invested in, amounts, expected yields, risk controls, and internal oversight related to the use of idle raised funds. The document includes references to board and shareholder meeting resolutions authorizing the cash management activities. It is a regulatory announcement about the company's capital management activities rather than a full financial report or earnings release. The content focuses on updates about financing activities related to the use of raised funds, fitting the category of Capital/Financing Update (CAP). The document length is about 5964 characters, which is substantive and not just a brief notice or report publication announcement. Therefore, the best classification is CAP with high confidence.
2023-10-24 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo New Gene Bio-tech Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It details the authorization, types of financial products used, amounts, expected yields, risk controls, and internal oversight related to the use of idle raised funds. The document includes tables of current and expired cash management products and references board and shareholder meeting resolutions approving the use of funds. There is no indication that this is a full financial report, audit, or earnings release. It is a specific update on capital management activities related to fundraising proceeds. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital usage activities.
2023-10-16 Chinese
回购进展情况公告
Transaction in Own Shares Classification · 100% confidence The document is titled '回购进展情况公告' which translates to 'Announcement of Repurchase Progress'. It details the company's share repurchase plan, including the purpose, method, price, quantity, funding source, implementation period, and progress as of a specific date. The text includes specific figures on shares repurchased, prices, and amounts paid. It is an update on the company's ongoing share buyback program rather than a full financial report or earnings release. The document length is 2086 characters, relatively short and focused on repurchase activity. Therefore, it fits the category of 'Transaction in Own Shares' (POS), which covers reports of the company buying back its own shares.
2023-10-08 Chinese
关于使用部分闲置募集资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Ningbo New Gen Bio-tech Co., Ltd. regarding the progress of using part of idle raised funds for cash management. It details the authorization, types of financial products invested in, amounts, expected yields, risk controls, and compliance with regulatory requirements. The document is a specific update on the company's cash management activities related to idle raised funds, not a full financial report, earnings release, or capital change. It is not a report publication announcement since it contains substantive details about the cash management products and amounts. The content fits best under Capital/Financing Update (CAP) as it relates to the use and management of raised capital funds for investment purposes.
2023-09-27 Chinese
北京炜衡(宁波)律师事务所关于宁波新芝生物科技股份有限公司2023年第二次临时股东大会之法律意见书
Regulatory Filings Classification · 65% confidence The document is a legal opinion letter (“法律意见书”) issued by Beijing Weiheng (Ningbo) Law Firm regarding the convening, procedures, attendance, and vote results of the company’s 2023 second extraordinary shareholders’ meeting. It does not itself constitute a financial report (e.g., 10-K or interim report), nor is it a notice of dividend, capital change, earnings release, or proxy solicitation. It is not an audit report or environmental disclosure. Rather, it is a compliance/legal document submitted as part of the company’s regulatory disclosure. Hence, it falls under the fallback category “Regulatory Filings (RNS).”
2023-09-11 Chinese
2023年第二次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal announcement of the resolutions passed at the company's 2023 second extraordinary general meeting of shareholders. It includes details about the meeting date, attendance, agenda items, voting results, and legal opinions confirming the validity of the meeting and resolutions. There are no financial statements or detailed financial data presented. The document primarily reports the voting results and decisions made at the shareholders' meeting. This fits the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is short (1741 characters), and it is not merely announcing the publication of a report but providing the actual voting results and resolutions. Therefore, the correct classification is DVA with high confidence.
2023-09-11 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.